PT in Focus For TrueCar, Inc. (NASDAQ:TRUE) and Ekso Bionics Holdings, Inc. (:EKSO)

Sell-side analysts are offering a consensus “Buy” rating on shares of TrueCar, Inc. (NASDAQ:TRUE). Using the following ratings scale: 1.0 Strong Buy, …

Share: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Facebook
  • LinkedIn
  • Twitter
  • Reddit
  • Slashdot

Leave a Reply

Your email address will not be published. Required fields are marked *